Blood test guides Life-Saving surgery timing in ovarian cancer trial
NCT ID NCT07382479
Summary
This international study aims to improve treatment for advanced ovarian cancer by personalizing the timing of surgery. Patients first receive three cycles of chemotherapy. A special blood test score (KELIM) then determines their next steps: patients with a good score have surgery sooner, while those with a poorer score receive more chemotherapy before surgery. The goal is to see if this tailored approach helps patients live longer and improves their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.